Vadim Uzberg
Partner at Negev Capital
📍 Limassol, Cyprus
Vadim Uzberg is a Partner at Negev Capital, a venture capital firm specializing in psychedelic medicine. He has an extensive background in private equity, including a long tenure as a Partner at Baring Vostok Capital Partners. He leverages deep expertise in M&A, deal structuring, and monitoring portfolio companies, and holds an economics degree from Voronezh State University.
His fund, Negev Capital, recently marked a major success with the acquisition of a clinical program from their portfolio company, Gilgamesh Pharmaceuticals, by AbbVie for $1. 2 billion.
Read the full overview →Experience
25 Years
Current Role
Partner
Location
Limassol, Cyprus
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Vadim cares about
Psychedelic Medicine
As a Partner at Negev Capital, his firm's primary investment focus is on companies developing psychedelic-based therapies for various health conditions.
Private Equity
Possesses a long and distinguished career in private equity, formerly as a Partner at Baring Vostok and currently with Negev Capital.
Career
Work history
12-2021
Partner
Negev Capital
3-2005 - 7-2020
Partner
Baring Vostok Capital Partners
1999 - 2005
Chief Financial Officer
Eagle Venture Partners
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
2008 - 2009
Education details unavailable
Harvard Business School
1994 - 2002
Economics
Voronezh State University
Social presence
Other Negev Capital Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.